Sandimmune and Zygomycosis - a phase IV clinical study of FDA data
Summary:
We study 11,288 people who take Sandimmune (cyclosporine) or have Zygomycosis. No report of Zygomycosis is found in people who take Sandimmune.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Sandimmune?
Sandimmune has active ingredients of cyclosporine. eHealthMe is studying from 6,694 Sandimmune users. Check the latest studies of Sandimmune.
What is Zygomycosis?
Zygomycosis (an infection caused by fungus) is found to be associated with 230 drugs and 675 conditions by eHealthMe. Check the latest studies of Zygomycosis.
No report is found.
Do you take Sandimmune and have Zygomycosis?
- Check whether Zygomycosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sandimmune:
- Sandimmune (6,694 reports)
Zygomycosis treatments and more:
- Zygomycosis (4,594 reports)
How severe was Zygomycosis and when was it recovered:
Expand to all the drugs that have ingredients of cyclosporine:
- Zygomycosis and drugs with ingredients of cyclosporine (252 reports)
Browse all side effects of Sandimmune:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Zygomycosis:
Browse all the conditions that are associated with Zygomycosis:
How the study uses the data?
The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Sandimmune) and Sandimmune (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ambien cause Vascular Occlusion? - 3 seconds ago
- Could B12 cause Quality Of Life Decreased? - 5 seconds ago
- Eliquis and Nosebleed for Women aged 40-49 - 13 seconds ago
- Eliquis and Nose Bleed for Women aged 40-49 - 13 seconds ago
- Eliquis and Nose Bleeds for Women aged 40-49 - 13 seconds ago
- Eliquis and Nosebleeds for Women aged 40-49 - 14 seconds ago
- Eliquis and Epistaxis for Women aged 40-49 - 14 seconds ago
- Eliquis and Bleeding From The Nose for Women aged 40-49 - 14 seconds ago
- Could Azelastine cause Skin Blushing/Flushing? - 21 seconds ago
- Could Ultravist 150 cause Death? - 21 seconds ago